Registro:

Referencias:

• Abdel-Malak, N.A., Srikant, C.B., Kristof, A.S., Magder, S.A., Di Battista, J.A., Hussain, S.N., Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8 (2008) Blood, 111, pp. 4145-4154
• Aboulghar, M.A., Mansour, R.T., Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures (2003) Hum. Reprod. Update, 9, pp. 275-289
• Abramovich, D., Parborell, F., Tesone, M., Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats (2006) Biol. Reprod., 75, pp. 434-441
• Abramovich, D., Rodriguez, C.A., Hernandez, F., Tesone, M., Parborell, F., Spatiotemporal analysis of the protein expression of angiogenic factors and their related receptors during folliculogenesis in rats with and without hormonal treatment (2009) Reproduction, 137, pp. 309-320
• Agrawal, R., Tan, S.L., Wild, S., Sladkevicius, P., Engmann, L., Payne, N., Bekir, J., Jacobs, H., Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome (1999) Fertil. Steril., 71, pp. 287-293
• Artini, P.G., Monti, M., Fasciani, A., Tartaglia, M.L., D'Ambrogio, G., Genazzani, A.R., Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilization (1998) Gynecol. Endocrinol., 12, pp. 243-247
• Budev, M.M., Arroliga, A.C., Falcone, T., Ovarian hyperstimulation syndrome (2005) Crit. Care Med., 33, pp. S301-S306
• Carmeliet, P., Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: a goal for therapeutic angiogenesis? (2000) Circ. Res., 87, pp. 176-178
• Cascone, I., Audero, E., Giraudo, E., Napione, L., Maniero, F., Philips, M.R., Collard, J.G., Bussolino, F., Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1 (2003) Blood, 102, pp. 2482-2490
• Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Yancopoulos, G.D., Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning (1996) Cell, 87, pp. 1161-1169
• Delvigne, A., Rozenberg, S., Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review (2002) Hum. Reprod. Update, 8, pp. 559-577
• Findlay, J.K., Angiogenesis in reproductive tissues (1986) J. Endocrinol., 111, pp. 357-366
• Fredriksson, L., Li, H., Eriksson, U., The PDGF family: four gene products form five dimeric isoforms (2004) Cytokine Growth Factor Rev., 15, pp. 197-204
• Geva, E., Jaffe, R.B., Role of vascular endothelial growth factor in ovarian physiology and pathology (2000) Fertil. Steril., 74, pp. 429-438
• Goede, V., Schmidt, T., Kimmina, S., Kozian, D., Augustin, H.G., Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis (1998) Lab. Invest., 78, pp. 1385-1394
• Golan, A., Ron-El, R., Herman, A., Soffer, Y., Weinraub, Z., Caspi, E., Ovarian hyperstimulation syndrome: an update review (1989) Obstet. Gynecol. Surv., 44, pp. 430-440
• Gruemmer, R., Motejlek, K., Berghaus, D., Weich, H.A., Neulen, J., Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells (2005) Reprod. Biol. Endocrinol., 3, p. 57
• Hanahan, D., Christofori, G., Naik, P., Arbeit, J., Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models (1996) Eur. J. Cancer, 32 A, pp. 2386-2393
• Hazzard, T.M., Molskness, T.A., Chaffin, C.L., Stouffer, R.L., Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval (1999) Mol. Hum. Reprod., 5, pp. 1115-1121
• Heldin, C.H., Westermark, B., Mechanism of action and in vivo role of platelet-derived growth factor (1999) Physiol. Rev., 79, pp. 1283-1316
• Heldin, C.H., Ostman, A., Ronnstrand, L., Signal transduction via platelet-derived growth factor receptors (1998) Biochim. Biophys. Acta, 1378, pp. F79-113
• Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., Betsholtz, C., Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse (1999) Development, 126, pp. 3047-3055
• Hurliman, A.K., Speroff, L., Stouffer, R.L., Patton, P.E., Lee, A., Molskness, T.A., Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation (2010) Fertil. Steril., 93, pp. 1493-1499
• Jones, N., Chen, S.H., Sturk, C., Master, Z., Tran, J., Kerbel, R.S., Dumont, D.J., A unique autophosphorylation site on Tie2/Tek mediates Dok-R phosphotyrosine binding domain binding and function (2003) Mol. Cell Biol., 23, pp. 2658-2668
• Kitajima, Y., Endo, T., Manase, K., Nishikawa, A., Shibuya, M., Kudo, R., Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors and vascular permeability of the ovaries of hyperstimulated rats (2004) Fertil. Steril., 81 (SUPPL. 1), pp. 842-849
• Kitajima, Y., Endo, T., Nagasawa, K., Manase, K., Honnma, H., Baba, T., Hayashi, T., Saito, H., Hyperstimulation and a gonadotropin-releasing hormone agonist modulate ovarian vascular permeability by altering expression of the tight junction protein claudin-5 (2006) Endocrinology, 147 (2), pp. 694-699
• Koos, R.D., Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture (1995) Biol. Reprod., 52, pp. 1426-1435
• Lee, A., Christenson, L.K., Stouffer, R.L., Burry, K.A., Patton, P.E., Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization (1997) Fertil. Steril., 68, pp. 305-311
• Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., Yancopoulos, G.D., Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis (1997) Science, 277, pp. 55-60
• Master, Z., Jones, N., Tran, J., Jones, J., Kerbel, R.S., Dumont, D.J., Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak (2001) EMBO J., 20, pp. 5919-5928
• McClure, N., Healy, D.L., Rogers, P.A., Sullivan, J., Beaton, L., Haning, R.V., Connolly, D.T., Robertson, D.M., Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome (1994) Lancet, 344, pp. 235-236
• Molskness, T.A., Stouffer, R.L., Burry, K.A., Gorrill, M.J., Lee, D.M., Patton, P.E., Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women (2004) Hum. Reprod., 19, pp. 822-830
• Molskness, T.A., Stouffer, R.L., Burry, K.A., Gorrill, M.J., Lee, D.M., Patton, P.E., Circulating levels of total angiopoietin-2 and the soluble Tie-2 receptor in women during ovarian stimulation and early gestation (2006) Fertil. Steril., 86, pp. 1531-1533
• Neufeld, G., Cohen, T., Gengrinovitch, S., Poltorak, Z., Vascular endothelial growth factor (VEGF) and its receptors (1999) FASEB J., 13, pp. 9-22
• Neulen, J., Yan, Z., Raczek, S., Weindel, K., Keck, C., Weich, H.A., Marme, D., Breckwoldt, M., Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome (1995) J. Clin. Endocrinol. Metab., 80, pp. 1967-1971
• Otrock, Z.K., Mahfouz, R.A., Makarem, J.A., Shamseddine, A.I., Understanding the biology of angiogenesis: review of the most important molecular mechanisms (2007) Blood Cells Mol. Dis., 39, pp. 212-220
• Parborell, F., Abramovich, D., Tesone, M., Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes (2008) Biol. Reprod., 78, pp. 506-513
• Pellicer, A., Albert, C., Mercader, A., Bonilla-Musoles, F., Remohi, J., Simon, C., The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor (1999) Fertil. Steril., 71, pp. 482-489
• Phillips, H.S., Hains, J., Leung, D.W., Ferrara, N., Vascular endothelial growth factor is expressed in rat corpus luteum (1990) Endocrinology, 127, pp. 965-967
• Redmer, D.A., Doraiswamy, V., Bortnem, B.J., Fisher, K., Jablonka-Shariff, A., Grazul-Bilska, A.T., Reynolds, L.P., Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum (2001) Biol. Reprod., 65, pp. 879-889
• Reynolds, L.P., Redmer, D.A., Growth and microvascular development of the uterus during early pregnancy in ewes (1992) Biol. Reprod., 47, pp. 698-708
• Reynolds, L.P., Grazul-Bilska, A.T., Redmer, D.A., Angiogenesis in the corpus luteum (2000) Endocrine, 12, pp. 1-9
• Rizk, B., Aboulghar, M., Smitz, J., Ron-El, R., The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome (1997) Hum. Reprod. Update, 3, pp. 255-266
• Scotti, L., Irusta, G., Abramovich, D., Tesone, M., Parborell, F., Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome (2011) Mol. Cell Endocrinol., 335, pp. 116-125
• Sleer, L.S., Taylor, C.C., Cell-type localization of platelet-derived growth factors and receptors in the postnatal rat ovary and follicle (2007) Biol. Reprod., 76, pp. 379-390
• Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N., Yancopoulos, G.D., Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis (1996) Cell, 87, pp. 1171-1180
• Thurston, G., Rudge, J.S., Ioffe, E., Zhou, H., Ross, L., Croll, S.D., Glazer, N., Yancopoulos, G.D., Angiopoietin-1 protects the adult vasculature against plasma leakage (2000) Nat. Med., 6, pp. 460-463
• Uutela, M., Wirzenius, M., Paavonen, K., Rajantie, I., He, Y., Karpanen, T., Lohela, M., Alitalo, K., PDGF-D induces macrophage recruitment, increased interstitial pressure and blood vessel maturation during angiogenesis (2004) Blood, 104, pp. 3198-3204
• von Otte, S., Paletta, J.R., Becker, S., Konig, S., Fobker, M., Greb, R.R., Kiesel, L., Nofer, J.R., Follicular fluid high density lipoprotein-associated sphingosine 1-phosphate is a novel mediator of ovarian angiogenesis (2006) J. Biol. Chem., 281, pp. 5398-5405
• Wulff, C., Wilson, H., Largue, P., Duncan, W.C., Armstrong, D.G., Fraser, H.M., Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid (2000) J. Clin. Endocrinol. Metab, 85, pp. 4302-4309
• Yoon, S.J., Kim, K.H., Chung, H.M., Choi, D.H., Lee, W.S., Cha, K.Y., Lee, K.A., Gene expression profiling of early follicular development in primordial, primary, and secondary follicles (2006) Fertil. Steril., 85, pp. 193-203

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------